Significados de copycat drugs en inglés

Its core business of making copycat drugs is under attack in the United States, where inflated drug prices are under growing scrutiny.

For the $400 billion-a-year pharmaceutical industry, these checks should stop copycat drugs made in the Third World flooding premium Western markets.

Slideshow (2 images) That pressure is exacerbated by efforts from U.S. health regulators to speed approval of copycat drugs, industry sources said.

Piramal is trying to focus on grass-root research and high-value patents and shift away from making copycat drugs, said Siddhant Khandekar, analyst at ICICI Direct.

Sanofi is fighting to protect this cash cow from copycat drugs in the courts, suing rival U.S. company Eli Lilly LLY.N for alleged patent infringements.

Teva, the world's largest generic drugmaker with annual sales of $20 billion, used its fortune from copycat drugs to move into the costlier innovative sector.